BCM
KZIA

Boxer Capital Management’s Kazia Therapeutics KZIA Stock Holding History

Boxer Capital Management’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.88M Buy
+560,000
New +$6.82M 0.59% 33

Other funds holding KZIA

FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Boxer Capital Management's KZIA Position: Q2 2026 in Review

Boxer Capital Management opened a new position in Kazia Therapeutics (KZIA) in Q2 2026: 560,000 shares worth $7.88M. The stake represents 0.59% of the portfolio and ranks #33 among its holdings.

36 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Boxer Capital Management held 560,000 shares of Kazia Therapeutics worth $7.88M as of Q2 2026.
  • Kazia Therapeutics was a new Boxer Capital Management position in Q2 2026.
  • Kazia Therapeutics made up 0.59% of Boxer Capital Management's portfolio in Q2 2026, its #33 holding.
  • 36 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.